4. Common Eye Disorders

Learning Objectives

• Differentiate cataract, glaucoma, AMD, and diabetic retinopathy by risk factors, presentation, and fundoscopic findings
• Distinguish acute angle-closure glaucoma from primary open-angle glaucoma and explain why the distinction is a medical emergency
• Compare dry versus wet age-related macular degeneration and their respective treatments
• Stage diabetic retinopathy and identify when a patient needs urgent ophthalmology referral
• Differentiate viral, bacterial, and allergic conjunctivitis and choose appropriate management for each
• Build a framework for the "red eye" that separates benign causes from sight-threatening emergencies

Quick Answer

Common eye disorders fall into two clinically useful buckets: chronic, progressive conditions (cataract, glaucoma, AMD, diabetic retinopathy) that threaten vision slowly and are managed through screening and staged treatment, and acute presentations (conjunctivitis, dry eye, the "red eye") that are usually benign but occasionally signal an emergency. The exam-critical skill is pattern recognition: painless progressive central blur with drusen points to AMD; painless peripheral field loss with cupped disc points to glaucoma; a diabetic with microaneurysms needs staging; a painful red eye with a fixed mid-dilated pupil is angle-closure glaucoma until proven otherwise. Getting the triage right — same-day emergency versus routine referral — matters more on boards and in practice than memorizing every treatment detail.

Chronic, Progressive Eye Disease

Cataract

A cataract is opacification of the crystalline lens, and it is the leading cause of reversible blindness worldwide. The lens is made of tightly packed, avascular protein fibers with no turnover mechanism — over decades, oxidative damage causes these proteins to aggregate and scatter light instead of transmitting it cleanly, so vision gradually clouds like looking through a frosted window rather than being lost abruptly.

Risk factors: age (the single biggest driver — nearly universal by the 80s), diabetes, prolonged corticosteroid use, UV exposure, smoking, and trauma. Congenital cataracts (from rubella, galactosemia, or Down syndrome) are a separate, urgent category because an opaque lens in infancy causes irreversible amblyopia if not corrected within weeks.

Presentation: painless, progressive blurring of vision, glare with bright lights or oncoming headlights, faded color perception, and — paradoxically — sometimes a temporary improvement in reading vision as the lens becomes more myopic ("second sight"). On exam, the red reflex is diminished or the lens appears visibly opaque.

Management: glasses help early on, but the only definitive treatment is surgery — phacoemulsification with intraocular lens (IOL) implantation, the most commonly performed surgery in the United States. Surgery is elective and timed to when the cataract meaningfully impairs the patient's daily function, not to a specific visual acuity cutoff.

Glaucoma

Glaucoma is a group of optic neuropathies characterized by progressive retinal ganglion cell death and a characteristic pattern of optic disc cupping and visual field loss. Elevated intraocular pressure (IOP) is the dominant modifiable risk factor, but it is not the definition — the disease is defined by the structural and functional damage, not the pressure number.

Primary open-angle glaucoma (POAG) is the common form: the trabecular meshwork drains aqueous humor too slowly, IOP creeps up over years, and the patient loses peripheral vision so gradually that it usually goes unnoticed until late-stage disease (central vision is preserved until the end, which is why screening matters). Risk factors include age, family history, African ancestry, myopia, and diabetes. It's picked up on routine exams via elevated IOP, cup-to-disc ratio >0.5 or asymmetry between eyes, and visual field testing showing arcuate scotomas. Treatment is a stepwise ladder: topical prostaglandin analogs (first-line, e.g., latanoprost) → beta-blockers, alpha-agonists, or carbonic anhydrase inhibitors → laser trabeculoplasty → filtering surgery (trabeculectomy) if medical therapy fails.

Acute angle-closure glaucoma (AACG) is the emergency version and behaves completely differently. In a predisposed eye (shallow anterior chamber, often hyperopic and older), the iris bows forward and suddenly blocks the trabecular meshwork — IOP can spike to 40–80 mmHg within hours. This presents with severe eye pain, headache, nausea and vomiting, halos around lights, a red eye, a fixed and mid-dilated pupil, and a rock-hard globe on palpation. It is a true ophthalmic emergency: untreated, it causes permanent optic nerve damage within hours to days. Treatment is IOP-lowering medications (acetazolamide, topical beta-blockers, alpha-agonists) followed by laser peripheral iridotomy to create a permanent drainage bypass.

Normal-tension glaucoma deserves a mention because it's a favorite trick question: optic nerve cupping and visual field loss occur with IOP staying within the "normal" 10–21 mmHg range, implicating vascular insufficiency to the optic nerve rather than pressure alone.

Age-Related Macular Degeneration (AMD)

AMD is degeneration of the macula — the central retina responsible for fine detail and color vision — and is the leading cause of irreversible central vision loss in people over 60 in developed countries. Peripheral vision is preserved, which is why patients with AMD can usually still navigate a room but struggle to read or recognize faces.

Dry (non-exudative) AMD accounts for about 90% of cases. Drusen (yellowish deposits of extracellular debris) accumulate under the retinal pigment epithelium, and the RPE and photoreceptors slowly atrophy. Progression is gradual over years. There is no cure, but the AREDS2 vitamin formulation (vitamin C, vitamin E, zinc, copper, lutein, zeaxanthin) slows progression in intermediate-to-advanced disease, and smoking cessation is one of the few genuinely modifiable risk factors.

Wet (exudative) AMD accounts for roughly 10% of cases but causes the majority of severe AMD vision loss. Abnormal choroidal neovascularization grows under the retina, and these fragile new vessels leak fluid and blood, causing sudden or rapidly progressive central distortion — classically metamorphopsia (straight lines appear wavy), tested at home with an Amsler grid. This is treated with intravitreal anti-VEGF injections (bevacizumab, ranibizumab, aflibercept), which can stabilize or even improve vision if started promptly — a genuine exam favorite because it's one of the few retinal conditions where treatment reverses rather than just halts damage.

OCT is the imaging test of choice for both forms — it shows drusen and RPE atrophy in dry AMD, and subretinal or intraretinal fluid in wet AMD. Fluorescein angiography confirms and characterizes active choroidal neovascularization.

Diabetic Retinopathy

Diabetic retinopathy is microvascular damage to the retina from chronic hyperglycemia and is the leading cause of blindness in working-age adults. Chronic high glucose damages retinal capillary pericytes and endothelial cells, weakening vessel walls and eventually triggering ischemia-driven neovascularization.

Non-proliferative diabetic retinopathy (NPDR) is the earlier stage: microaneurysms, dot-and-blot hemorrhages, and hard exudates on fundoscopy. Vision may be normal or mildly reduced unless macular edema is present.

Proliferative diabetic retinopathy (PDR) is the advanced, sight-threatening stage: retinal ischemia drives VEGF-mediated neovascularization, and these fragile new vessels can bleed into the vitreous (vitreous hemorrhage) or contract and pull the retina off the wall (tractional retinal detachment).

Diabetic macular edema can occur at any stage of retinopathy and is actually the most common cause of vision loss in diabetics — fluid leaks into the macula from incompetent capillaries, independent of the proliferative/non-proliferative staging.

Management is staged: tight glycemic and blood pressure control slows progression at every stage; PDR is treated with panretinal laser photocoagulation to reduce the ischemic drive for neovascularization; macular edema and PDR both respond to intravitreal anti-VEGF injections. All diabetics need annual dilated fundus exams starting at diagnosis for type 2 diabetes (or five years after diagnosis for type 1), because retinopathy is often asymptomatic until advanced.

Acute Presentations: Dry Eye and Conjunctivitis

Dry Eye Syndrome

Dry eye disease results from either insufficient tear production (aqueous-deficient) or excessive tear evaporation (evaporative, usually from meibomian gland dysfunction) — the two mechanisms often coexist. Risk factors include aging, prolonged screen use (reduced blink rate), contact lens wear, certain medications (antihistamines, anticholinergics), and autoimmune disease — Sjögren's syndrome is the classic systemic cause and should be considered in dry eye plus dry mouth.

Symptoms are a burning or gritty sensation, intermittent blurred vision that improves with blinking, and — counterintuitively — reflex excessive tearing when the ocular surface becomes irritated enough to trigger compensatory lacrimation. Management is stepwise: artificial tears first, then punctal plugs to retain natural tears, then topical cyclosporine (Restasis) or lifitegrast to reduce surface inflammation, reserving surgery for severe refractory cases.

Conjunctivitis

Conjunctivitis is inflammation of the conjunctiva, and telling the three types apart is one of the highest-yield discrimination tasks in ophthalmology.

• Viral conjunctivitis (most common overall, usually adenovirus): watery discharge, often starts in one eye and spreads to the other, preauricular lymphadenopathy, associated with recent upper respiratory infection. Highly contagious. Self-limited — treatment is supportive (cool compresses, lubrication, strict hand hygiene) since antibiotics do not help a viral infection.
• Bacterial conjunctivitis (Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae in children): purulent, thick discharge that causes eyelids to be stuck together on waking. Treated with topical antibiotic drops or ointment.
• Allergic conjunctivitis: bilateral itching (the defining symptom — if it doesn't itch, it's probably not allergic), watery discharge, often with a history of atopy or seasonal triggers. Treated with topical antihistamines/mast cell stabilizers, and oral antihistamines if needed.

The exception that changes everything: gonococcal conjunctivitis presents with copious, rapidly progressive purulent discharge and is a true emergency because it can perforate the cornea within hours — it needs systemic (not just topical) antibiotics and same-day ophthalmology involvement.

The Red Eye: A Triage Framework

Not every red eye is conjunctivitis, and distinguishing benign from sight-threatening causes is a core clinical skill.

The single most important triage question is whether there is real pain, photophobia, or vision change layered on top of the redness. Simple conjunctivitis is uncomfortable but not truly painful and does not blur vision (beyond the transient blur from discharge). Anything with true pain, a non-reactive or irregular pupil, ciliary flush (redness concentrated around the limbus rather than diffusely), or reduced visual acuity should be treated as a red flag until an ophthalmologist says otherwise.

Key Terms

Term	Definition	Related Concept
Cataract	Opacification of the crystalline lens causing progressive, painless vision loss	Phacoemulsification, diabetes, corticosteroid use
Cup-to-disc ratio	Proportion of the optic disc occupied by the central cup; increases with ganglion cell loss	Glaucoma, disc cupping, IOP
Angle-closure glaucoma	Emergency in which the iris blocks aqueous outflow, causing a rapid IOP spike	Fixed mid-dilated pupil, laser iridotomy
Drusen	Yellowish extracellular deposits beneath the retinal pigment epithelium	Dry AMD, AREDS2
Choroidal neovascularization	Abnormal new blood vessel growth under the retina that leaks fluid or blood	Wet AMD, anti-VEGF therapy
Metamorphopsia	Distortion of straight lines into wavy lines, tested with the Amsler grid	Wet AMD
Microaneurysm	Small outpouching of a weakened retinal capillary; earliest visible sign of diabetic retinopathy	Non-proliferative diabetic retinopathy
Panretinal photocoagulation	Laser therapy applied to the peripheral retina to reduce the ischemic drive for neovascularization	Proliferative diabetic retinopathy
Ciliary flush	Ring of redness concentrated around the limbus rather than spread diffusely	Uveitis, keratitis, angle-closure glaucoma
Meibomian gland dysfunction	Blockage or dysfunction of the oil-secreting glands in the eyelid, causing evaporative tear loss	Evaporative dry eye

Common Mistakes

Misconception: All red, irritated eyes are "just conjunctivitis" and can be treated the same way. Why it's wrong: Several sight-threatening conditions — acute angle-closure glaucoma, uveitis, corneal ulcer, hyphema — also present with a red eye, but they carry pain, photophobia, or pupil/vision abnormalities that conjunctivitis does not. Correct understanding: Always screen for true pain, photophobia, pupil irregularity, and visual acuity change before assuming a red eye is benign conjunctivitis.

Misconception: Glaucoma always causes noticeable symptoms early, so a patient without complaints doesn't have it. Why it's wrong: Primary open-angle glaucoma destroys peripheral visual field so gradually and symmetrically that patients typically don't notice until irreversible damage has already occurred; central vision is spared until very late. Correct understanding: POAG is detected through screening (IOP, disc exam, visual fields), not by waiting for symptoms — this is why routine eye exams matter even in asymptomatic patients over 40.

Misconception: Diabetic retinopathy severity always tracks with how blurry the patient's vision feels. Why it's wrong: Significant non-proliferative or even early proliferative disease can be entirely asymptomatic, while vision loss only appears once macular edema or a vitreous hemorrhage develops — often after structural damage is already present. Correct understanding: Every diabetic needs scheduled dilated fundus exams regardless of symptoms, because retinopathy staging depends on fundoscopic findings, not subjective vision.

Comparison and Connections

Feature	Cataract	POAG	Wet AMD	Diabetic Retinopathy
Onset	Gradual, painless	Gradual, painless (asymptomatic until late)	Sudden or rapidly progressive	Gradual, often asymptomatic until advanced
Vision affected	Overall blur, glare	Peripheral field first, central spared until late	Central vision, metamorphopsia	Variable; macular edema causes central blur
Key exam finding	Diminished red reflex, opaque lens	Cup-to-disc ratio >0.5, elevated IOP	Subretinal fluid on OCT	Microaneurysms, hemorrhages, neovascularization
First-line treatment	Surgery (phacoemulsification + IOL)	Topical prostaglandin analog	Intravitreal anti-VEGF	Glycemic control; anti-VEGF or laser if advanced
Reversibility	Fully reversible with surgery	Damage is permanent; treatment halts progression	Can improve with prompt anti-VEGF	Damage is largely permanent; treatment halts progression

Practice Questions

Recall

1. What are the three main types of conjunctivitis, and what discharge pattern distinguishes each? Answer guidance: Viral (watery, often unilateral spreading to bilateral, preauricular lymphadenopathy), bacterial (purulent, eyelids stuck together on waking), allergic (watery with prominent itching, usually bilateral).

2. Name the two subtypes of age-related macular degeneration and give the approximate proportion of cases each represents. Answer guidance: Dry (non-exudative) AMD, about 90% of cases; wet (exudative) AMD, about 10% of cases but responsible for most severe vision loss.

Understanding

3. Explain why primary open-angle glaucoma is often not diagnosed until significant optic nerve damage has occurred. Answer guidance: POAG destroys peripheral visual field gradually and symmetrically in both eyes; central vision, which patients rely on for most tasks, is preserved until late-stage disease, so there is no symptomatic warning until damage is already substantial.

4. Why does wet AMD cause more severe vision loss than dry AMD despite being less common? Answer guidance: Wet AMD involves choroidal neovascularization with leaking, fragile vessels that cause acute fluid accumulation, hemorrhage, and rapid central distortion, whereas dry AMD progresses through slow RPE and photoreceptor atrophy over years.

Application

5. A 70-year-old presents with sudden severe eye pain, headache, nausea, and halos around lights. Exam shows a red eye with a fixed, mid-dilated pupil and a rock-hard globe. What is the diagnosis and immediate management? Answer guidance: Acute angle-closure glaucoma. Immediate IOP-lowering therapy (topical beta-blocker, alpha-agonist, and acetazolamide) followed by laser peripheral iridotomy once IOP is controlled. This is an ophthalmic emergency.

6. A 55-year-old diabetic with well-controlled HbA1c has a routine dilated fundus exam showing microaneurysms and dot-blot hemorrhages but no neovascularization. How would you stage this, and what is the management priority? Answer guidance: Non-proliferative diabetic retinopathy. Priority is continued tight glycemic and blood pressure control, with annual (or more frequent if macular edema is suspected) ophthalmology follow-up; laser or anti-VEGF is reserved for macular edema or progression to proliferative disease.

Analysis

7. Compare the mechanism and treatment rationale of anti-VEGF therapy in wet AMD versus proliferative diabetic retinopathy. Why does the same drug class work for both? Answer guidance: Both conditions are driven by VEGF-mediated abnormal blood vessel growth or leakage — choroidal neovascularization in wet AMD and retinal neovascularization from ischemia in PDR. Anti-VEGF agents block this shared final common pathway, reducing leakage and regressing abnormal vessels regardless of the underlying disease.

8. A patient with known cataracts also reports new peripheral field loss on formal testing. How would you determine whether the field loss is from the cataract itself or a separate process, and why does this distinction matter? Answer guidance: Cataracts cause diffuse blur and glare but do not produce a discrete peripheral field defect on formal perimetry; a genuine field cut points to a separate process such as glaucoma. This matters because cataract surgery will not fix glaucomatous field loss, and untreated glaucoma will continue to progress even after successful cataract surgery — both conditions may need to be managed in parallel.

FAQ

1. Can cataracts come back after surgery? The natural lens itself is removed and replaced with an artificial IOL, so the original cataract cannot recur. However, up to 20–30% of patients develop posterior capsule opacification (clouding of the thin membrane left behind to support the IOL), sometimes called a "secondary cataract." This is easily treated with a quick outpatient YAG laser capsulotomy.

2. Is glaucoma curable? No. Vision and optic nerve tissue already lost to glaucoma cannot be restored, so treatment goals are to lower IOP and halt further damage, not to reverse existing field loss. This is why early detection through routine screening is so important — the earlier treatment starts, the more visual field is preserved.

3. Why do eye doctors dilate the pupils during routine exams? Dilation allows a much wider view of the peripheral retina and a clearer view of the optic disc and macula, which is essential for catching early diabetic retinopathy, AMD, and glaucomatous cupping before symptoms appear. Undilated exams can miss significant peripheral pathology.

4. Does having diabetic retinopathy mean a patient will go blind? Not if it's caught and managed. With regular screening, glycemic control, and timely laser or anti-VEGF treatment when indicated, most patients preserve functional vision. Vision loss occurs mainly when retinopathy goes undetected or untreated until advanced macular edema, vitreous hemorrhage, or tractional retinal detachment develops.

5. How can you tell viral conjunctivitis apart from a serious cause of red eye at home? Viral conjunctivitis causes watery discharge and irritation but not true pain, significant photophobia, or blurred vision beyond what clears with blinking. Any red eye accompanied by real pain, marked light sensitivity, a change in pupil appearance, or vision loss needs same-day evaluation rather than home management, since those features suggest uveitis, keratitis, or angle-closure glaucoma.

Quick Revision

• Cataract: painless lens opacification; risk factors include age, diabetes, steroids, UV; only definitive treatment is phacoemulsification with IOL
• POAG: gradual peripheral field loss, cup-to-disc ratio >0.5, central vision spared until late; first-line treatment is topical prostaglandin analogs
• Acute angle-closure glaucoma: EMERGENCY — painful red eye, fixed mid-dilated pupil, rock-hard globe, halos; treat IOP first, then laser iridotomy
• Normal-tension glaucoma: optic nerve damage with IOP in the normal 10–21 mmHg range
• Dry AMD (~90%): drusen, slow RPE atrophy; managed with AREDS2 vitamins and smoking cessation
• Wet AMD (~10%): choroidal neovascularization, metamorphopsia, sudden central distortion; treated with intravitreal anti-VEGF
• Diabetic retinopathy: NPDR (microaneurysms, hemorrhages) progresses to PDR (neovascularization, risk of vitreous hemorrhage/retinal detachment); macular edema can occur at any stage and is the most common cause of vision loss
• All diabetics need annual dilated fundus exams starting at diagnosis (type 2) or five years post-diagnosis (type 1)
• Conjunctivitis: viral (watery, unilateral-to-bilateral spread), bacterial (purulent, lids stuck shut), allergic (itching is the hallmark)
• Gonococcal conjunctivitis is an emergency — copious purulent discharge with risk of corneal perforation
• Dry eye: aqueous-deficient or evaporative (meibomian gland dysfunction); stepwise treatment from artificial tears to cyclosporine
• Red eye triage: true pain, photophobia, pupil abnormality, or vision change = red flag requiring urgent ophthalmology evaluation

Related Topics

Prerequisites: Basic anatomy of the eye, the visual pathway, principles of clinical eye examination (slit lamp, ophthalmoscopy, tonometry)

Related Topics: Ophthalmic imaging (OCT, fluorescein angiography), diabetic systemic complications, ocular pharmacology (anti-VEGF agents, IOP-lowering drops), neuro-ophthalmology and visual field defects

Next Topics: Ocular Emergencies and Trauma, Pediatric Ophthalmology and Strabismus, Ophthalmic Pharmacology